Shaikh Raja, Munoz Fernando Gomez
Department of Radiology, Boston Children's Hospital and Harvard Medical School, 300 Longwood, Boston, MA-02115, USA.
Hospital Clinic-Hospital Sant Joan de Deu, C/ Villarroel 170, Passeig de Sant Joan de Déu, 2, Esplugues del Llobregat, 08950, Barcelona, Spain.
CVIR Endovasc. 2021 Jan 2;4(1):2. doi: 10.1186/s42155-020-00190-7.
The demand for interventional oncological (IO) treatment of pediatric cancers is becoming increasingly common, at least at several tertiary care institutions. The data and techniques used in pediatric IO are largely extrapolated from experience in adult patients. The management of pediatric tumors differs from that in adults in several categories, such as, the curative intent of treatment, wide use of general anesthesia, aggressive pain management, potentially longer hospital stay, variation in chemotherapy dosing etc. Additionally, pediatric cancers are managed by protocols directed by national and international oncology groups such as the Children's Oncology Group (COG). Consequently, the translation and adoption of these techniques is gradual, but there is a noticeable uptrend due to the growing need. This review will update the current endovascular IO treatments for common pediatric liver, renal, bone and soft tissue tumors.
至少在几家三级医疗机构中，小儿癌症的介入肿瘤学（IO）治疗需求正变得越来越普遍。小儿IO所使用的数据和技术很大程度上是从成人患者的经验中推断出来的。小儿肿瘤的管理在几个方面与成人不同，例如治疗的治愈意图、全身麻醉的广泛使用、积极的疼痛管理、可能更长的住院时间、化疗剂量的差异等。此外，小儿癌症由国家和国际肿瘤学组织（如儿童肿瘤学组（COG））指导的方案进行管理。因此，这些技术的转化和应用是渐进的，但由于需求不断增长，有明显的上升趋势。本综述将更新目前针对常见小儿肝脏、肾脏、骨骼和软组织肿瘤的血管内IO治疗方法。
